SEC filings

Thermo Fisher Scientific (TMO)

Recent filings Thermo Fisher Scientific made with the SEC, newest first. Most have a short AI-generated summary, and every one links to the original.

CIK 0000097745All filings on SEC.gov

AI-generated summary
  1. 8-KCurrent report

    Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

    Thermo Fisher Scientific announced that Executive Vice President Michael D. Shafer will retire effective December 31, 2026.

  2. 10-QQuarterly report

    Quarterly report

    Thermo Fisher Scientific reported third-quarter 2026 revenues of $12.137 billion, up 9% year over year, with GAAP diluted EPS of $4.64 and adjusted EPS of $6.68, and said organic revenue growth was 6% for the quarter. …

  3. 8-KCurrent report

    Results of Operations and Financial Condition

    Thermo Fisher Scientific reported third-quarter 2026 revenue of $12.14 billion, up 9% with 6% organic growth, alongside GAAP diluted EPS of $4.64 (up 9%) and adjusted EPS of $6.68 (up 15%), and said it would provide updated 2026 guidance…

  4. 10-QQuarterly report

    Quarterly report

    Thermo Fisher Scientific reported second-quarter 2026 revenue of $11.99 billion, up 10% from a year earlier with 5% organic growth, and adjusted earnings per share of $6.03, saying customer activity continued to strengthen across its end…

  5. 8-KCurrent report

    Results of Operations and Financial Condition

    Thermo Fisher Scientific reported second-quarter 2026 revenue of $11.99 billion, up 10% including 5% organic growth, with GAAP diluted EPS of $4.68 and adjusted EPS of $6.03; CEO Marc Casper said end markets continued to strengthen. …

Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.

Follow Thermo Fisher Scientific in Readster

Add Thermo Fisher Scientific to your watchlist and its SEC filings reach your brief alongside the news about it, every line cited to its source. Readster also follows topics, people, newsletters and podcasts.

No credit card. When the trial ends, you move to Readster Free unless you subscribe.